UPDATED May 03, 2024
Over $1bn in market cap, profitable and undervalued based on cash flows.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MSFT | US$406.66 | 0.08% | 30.9% | US$3.0t | US$476.88 | PE35.1x | E12.7% | 0.7% | Software | ||
GOOGL | US$167.24 | -2.7% | 58.4% | US$2.1t | US$190.91 | PE25.1x | E12.2% | 0.5% | Media | ||
AMZN | US$186.21 | 3.7% | 76.2% | US$1.9t | US$216.82 | PE51.4x | E21.4% | n/a | Retail | ||
META | US$451.96 | 2.0% | 94.2% | US$1.1t | US$518.35 | PE25.1x | E12.2% | 0.4% | Media | ||
LLY | US$734.97 | 0.2% | 71.8% | US$661.8b | US$848.35 | PE107.8x | E27.0% | 0.7% | Pharmaceuticals & Biotech | ||
2330 | NT$780.00 | -0.3% | 56.0% | NT$20.2t | NT$912.98 | PE23.6x | E16.1% | 1.8% | Semiconductors | ||
AVGO | US$1,278.11 | -4.9% | 102.8% | US$574.0b | US$1,501.46 | PE51.1x | E23.4% | 1.6% | Semiconductors | ||
JPM | US$190.51 | -1.5% | 39.3% | US$550.4b | US$207.83 | PB1.8x | E-1.3% | 2.4% | Banks | ||
NOVO B | kr.850.60 | -4.1% | 55.5% | kr.3.8t | kr.908.80 | PE42.3x | E13.0% | 1.1% | Pharmaceuticals & Biotech | ||
WMT | US$59.82 | -0.6% | 18.2% | US$481.3b | US$65.09 | PE31.1x | E10.7% | 1.4% | Consumer Retailing | ||
XOM | US$116.00 | -1.7% | 6.7% | US$458.3b | US$131.03 | PE13.9x | E1.5% | 3.3% | Energy | ||
UNH | US$492.45 | -0.6% | -0.4% | US$453.6b | US$567.36 | PE29.5x | E19.5% | 1.5% | Healthcare | ||
700 | HK$364.40 | 4.6% | 6.3% | HK$3.4t | HK$417.69 | PE27.3x | E15.1% | 0.9% | Media | ||
MA | US$443.58 | -4.1% | 15.3% | US$410.1b | US$512.87 | PE34.8x | E11.7% | 0.6% | Diversified Financials | ||
PG | US$164.46 | 2.0% | 5.4% | US$386.7b | US$170.09 | PE26.1x | E7.2% | 2.4% | Household | ||
A005930 | ₩77,600.00 | 1.2% | 19.2% | ₩516.4t | ₩103,324.32 | PE26.8x | E22.7% | 1.9% | Tech | ||
JNJ | US$149.27 | 2.1% | -8.2% | US$359.2b | US$173.26 | PE21x | E7.0% | 3.3% | Pharmaceuticals & Biotech | ||
HD | US$342.85 | 2.3% | 18.4% | US$332.5b | US$384.85 | PE22.4x | E4.3% | 2.6% | Retail | ||
COST | US$743.90 | 2.0% | 49.1% | US$324.8b | US$775.86 | PE48.6x | E7.5% | 0.6% | Consumer Retailing | ||
MRK | US$127.51 | -2.8% | 8.4% | US$323.0b | US$141.64 | PE140.1x | E24.9% | 2.4% | Pharmaceuticals & Biotech | ||
ORCL | US$115.80 | -1.2% | 19.4% | US$316.0b | US$136.92 | PE29.9x | E14.6% | 1.4% | Software | ||
CVX | US$160.25 | -3.4% | 0.03% | US$296.2b | US$183.11 | PE14.6x | E2.5% | 4.1% | Energy | ||
600519 | CN¥1,705.00 | -0.3% | -2.6% | CN¥2.1t | CN¥2,157.44 | PE27.5x | E12.7% | 2.9% | Food, Beverage & Tobacco | ||
ABBV | US$163.79 | 2.6% | 10.6% | US$290.0b | US$182.31 | PE48.7x | E23.3% | 3.8% | Pharmaceuticals & Biotech |